Vinsamlegast notið þetta auðkenni þegar þið vitnið til verksins eða tengið í það: https://hdl.handle.net/1946/51627
Production of biotech drugs in Iceland.
We are currently experiencing a technological revolution in many respects, with the pharmaceutical group excelling in the use of biotechnology to produce drugs that deliver better results and ensure their safety. In an era of significant economic and demographic challenges, it is important for patients to obtain the highest quality outcomes and revolutionize treatments with new and effective drugs for acute and chronic diseases, known as biosimilars.
These biological products result from cutting-edge research that has changed the lives of many patients with novel treatments for various diseases, increasing survival in certain types of oncological diseases. That is why it is important to know what biosimilars are, how they are made, their characteristics, the respective uses that can be given to them, and the regulations regarding their safe use.
| Skráarnafn | Stærð | Aðgangur | Lýsing | Skráartegund | |
|---|---|---|---|---|---|
| Lokaverkefni Milena sent 22.05.25.pdf | 533,08 kB | Opinn | Heildartexti | Skoða/Opna |